Adage Capital Partners’s PRA Health Sciences, Inc. PRAH Stock Holding History

Adage Capital Partners’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,030,000	Closed	-$170M	–	1135
2021 Q2	$170M	Buy	1,030,000 +330,000	+47%	+$55.1M	0.33%	63
2021 Q1	$107M	Buy	+700,000	New	+$95.1M	0.22%	102
2017 Q3	–	Sell	-200,000	Closed	-$15M	–	772
2017 Q2	$15M	Sell	200,000 -250,000	-56%	-$17.3M	0.04%	481
2017 Q1	$29.4M	Buy	450,000 +50,000	+13%	+$2.94M	0.07%	326
2016 Q4	$22M	Buy	400,000 +197,900	+98%	+$10.9M	0.06%	347
2016 Q3	$11.4M	Buy	+202,100	New	+$9.91M	0.03%	502

Other funds holding PRAH

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Adage Capital Partners's PRAH Position: Q3 2021 in Review

Adage Capital Partners sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 1,030,000 shares — an estimated $170M sold.

Adage Capital Partners first reported a position in PRAH in Q3 2016 and held it in 6 quarters. The position peaked at $170M in Q2 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

Adage Capital Partners reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
Adage Capital Partners sold 1,030,000 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $170M.
Adage Capital Partners first reported a position in PRA Health Sciences, Inc. in Q3 2016 and held it in 6 quarters.
Adage Capital Partners's PRA Health Sciences, Inc. position peaked at $170M in Q2 2021.
1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Adage Capital Partners's 13F filing for Q3 2021, filed 15 Nov 2021.